The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. (Q53327434)
Jump to navigation
Jump to search
scientific article published in January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. |
scientific article published in January 1997 |
Statements
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. (English)
1 reference
Bodick NC
1 reference
Offen WW
1 reference
Shannon HE
1 reference
Satterwhite J
1 reference
Lucas R
1 reference
van Lier R
1 reference
Paul SM
1 reference
1 January 1997
1 reference
11 Suppl 4
1 reference
S16-22
1 reference
Identifiers
1 reference